Login
Toggle navigation
Videos
Categories
Trending
Adelene Pewrkins, CEO, Infinity Pharmaceuticals Inc
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Adelene Perkins (Infinity Pharmaceuticals) Shares Career Advice
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
AMC Networks Interim CEO Matt Blank on Linear Media’s Resilience vs. Streaming Platforms | Matt Blank, CEO, AMC Networks Inc.
00:10:00
Emphasizing Talent Development and Environmental Responsibility in Energy Leadership | Manny Rubio , CEO, Aboitiz Power Corp.
00:10:00
Exploring NuEnergy Gas's Indonesian Coal Seam Gas Projects: Insights from Leadership|
00:10:00
Cristian Jimenez on Pride and Inclusivity at Boart Longyear
00:10:00
Strategic Private Investments in Global Emerging Markets
00:00:00
Stephen M. Ansell, M.D., Ph.D. / Ask Mayo Clinic: Lymphoma
00:10:00
Skills Gap: Insights from EIF Experts | Antonia Botsari - Senior Research Analyst, European Investment Fund
00:10:00
our global network and operational resources make us more valuable than capital alone|Reeta, Co-Founder,The Silverfern Group, Inc.
00:10:00
AAK AB Q2 2019 Report: CFO Fredrik Nilsson's Commentary | Fredrik Nilsson, CFO , AAK AB.
00:10:00
Adopting Open Data for Finance Could Boost Economic Growth|Kabir Kumar,Director,Flourish Ventures
00:10:00
Tharisa: Thriving as a Leading Low-Cost Producer of PGMs and Chrome in South Africa
00:10:00
Webinar: The Role of Indonesia in the Nickel Industry